Piramal Pharma Q4 FY26 Conference Call Transcript Available

Piramal Pharma Limited has made the transcript of its Q4 FY26 results conference call available on its website.
The call was held on 29th April 2026 to discuss audited standalone and consolidated financial results.
This disclosure is a regulatory compliance filing submitted to BSE and NSE.
The company secretary confirmed the availability of the transcript for investor reference.